Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Equity Average (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Equity Average for 16 consecutive years, with $18.6 billion as the latest value for Q4 2025.

  • Quarterly Equity Average rose 14.23% to $18.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.6 billion through Dec 2025, up 14.23% year-over-year, with the annual reading at $17.4 billion for FY2025, 43.78% down from the prior year.
  • Equity Average for Q4 2025 was $18.6 billion at Bristol Myers Squibb, up from $8.5 billion in the prior quarter.
  • The five-year high for Equity Average was $45.3 billion in Q4 2023, with the low at -$28.4 billion in Q3 2021.
  • Average Equity Average over 5 years is $3.6 billion, with a median of -$50.0 million recorded in 2022.
  • The sharpest move saw Equity Average soared 11647.58% in 2023, then plummeted 316.1% in 2025.
  • Over 5 years, Equity Average stood at -$2.4 billion in 2021, then surged by 83.5% to -$392.0 million in 2022, then skyrocketed by 11647.58% to $45.3 billion in 2023, then plummeted by 64.12% to $16.2 billion in 2024, then rose by 14.23% to $18.6 billion in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $18.6 billion, $8.5 billion, and -$631.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.